scholarly journals Identifying Risk Factors for a High Lymph Node Ratio (over 0.8) in Papillary Thyroid Carcinoma Patients

2020 ◽  
Author(s):  
Yuewu Liu ◽  
LY Zhang ◽  
xiaoyi li ◽  
hongfeng liu

Abstract Background Despite the majority of papillary thyroid carcinoma (PTC) patients has an excellent prognosis, central lymph node metastases (CLNM) are common. The relationship between CLNM and prognosis is still controversial, however, a certain lymph node ratio (LNR) has been reported to show significantly worse prognosis for PTC patients. Therefore, the extent of CLNM seems to play an important role in predicting the recurrence and survival of PTC. The aim of this study is to determine the risk factors for a high LNR (over 0.8) in central compartment in PTC patients. Methods A retrospective cohort study was conducted on PTC patients who underwent total thyroidectomy or lobectomy plus central lymph node dissection (CLND) between January 2011 and December 2015. Patients with an LNR over 0.8 was defined as Group A, and patients with an LNR 0 was defined as group B. The clinical and pathological factors such as gender, age, tumor size, tumor number, extracapsular spread (ECS), MACIS score, and co-existence of chronic lymphocytic thyroiditis (CLT)were compared between different LNR groups.Results Univariate analysis found high LNR to be associated with male gender, young age(<40 years) ,larger tumor (≥1 cm), ECS and absence of chronic lymphocytic thyroiditis. Multivariate logistic regression showed male gender (p = 0.007, OR = 3.79), young age(<40 years) (p = 0.000, OR = 0.159), larger tumor (≥1 cm) (p =0.033, OR = 2.530), and absence of chronic lymphocytic thyroiditis (p = 0.036, OR = 0.321) to be independent predictors for high LNR in PTC patients Conclusions Male gender, younger age (<40 years), larger tumor (≥1 cm) and absence of chronic lymphocytic thyroiditis were risk factors of high LNR. We recommend a prophylactic CLND should be considered in PTC patients with such risk factors.

2016 ◽  
Vol 2016 ◽  
pp. 1-5 ◽  
Author(s):  
Huanhuan Yan ◽  
Xiaoqian Zhou ◽  
Hui Jin ◽  
Xiang Li ◽  
Miao Zheng ◽  
...  

Background. Papillary thyroid carcinoma (PTC) with central lymph node metastases (CLNMs) is common. The objective of this study was to investigate the incidence and risk factors of lymph node metastasis patients with PTC.Patients and Methods. Between January 2013 and February 2015, a retrospective study of 543 patients with PTC undergoing hemithyroidectomy or total thyroidectomy with routine central lymph node dissection (CLND) was analyzed. Clinicopathologic risk factors for CLNM were studied using univariate and multivariate analysis by SPSS 22.0 software.Results. The incidence of CLNMs in PTC patients was 38.1% (207/543). In the multivariate analysis, male gender (p<0.001, OR: 1.984), age <45 years (p<0.001, OR: 1.934), bilaterality (p=0.006, OR: 1.585), tumor size ≥0.25 cm (p=0.001, OR: 7.655), and external extension (p=0.001, OR: 7.579) were independent risk factors of CLNMs. Furthermore, in PTC patients with tumor size <0.25 cm, all 7 males and 21 patients with unilaterality were not found to have CLNMs.Conclusions. CLNMs are prevalent in the PTC patients with the following risk factors: male gender, age <45 years, bilaterality, tumor size ≥0.25 cm, and external extension. PTC patients with tumor size <0.25 cm, male patients, and patients with unilateral lesion could be considered safe from CLNMs.


Surgery ◽  
2016 ◽  
Vol 159 (1) ◽  
pp. 31-40 ◽  
Author(s):  
Paritosh Suman ◽  
Chi-Hsiung Wang ◽  
ShabirHusain S. Abadin ◽  
Tricia A. Moo-Young ◽  
Richard A. Prinz ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Yuanyuan Wang ◽  
Chang Deng ◽  
Xiujie Shu ◽  
Ping Yu ◽  
Huaqiang Wang ◽  
...  

BackgroundPapillary thyroid cancer (PTC) in clinically lymph node-negative (cN0) patients is prone toward lymph node metastasis. As a risk factor for tumor persistence and local recurrence, lateral lymph node metastasis (LLNM) is related to the number of central lymph node metastases (CLNMs).MethodsWe performed LLNM risk stratification based on the number of CLNMs for cN0 PTC patients who underwent thyroidectomy and lymph node dissection between January 2013 and December 2018. A retrospective analysis was applied to the 274 collected patients with 1-2 CLNMs. We examined the clinicopathological characteristics of the patients and constructed a LASSO model.ResultsIn the 1–2 CLNM group, tumors &gt;10 mm located in the upper region and nodular goiters were independent risk factors for LLNM. Specifically, tumors &gt;20 mm and located in the upper region contributed to metastasis risk at level II. Hashimoto’s thyroiditis reduced this risk (p = 0.045, OR = 0.280). Age ≤ 30 years and calcification (microcalcification within thyroid nodules) correlated with LLNM. The LASSO model divided the population into low- (25.74%) and high-risk (57.25%) groups for LLNM, with an AUC of 0.715.ConclusionsFor patients with 1–2 CLNMs, young age, calcification, nodular goiter, tumor &gt;10 mm, and tumor in the upper region should alert clinicians to considering a higher occult LLNM burden. Close follow-up and therapy adjustment may be warranted for high-risk patients.


Sign in / Sign up

Export Citation Format

Share Document